Epstein Secrets

s man pleaded guilty Thursday to one count of misinformation and hoaxes related to a Dec. 2018 case where he planted a fake bomb in the middle of a Kansas City Rail Line railroad track in Dallas, according to the U.S. Department of Justice." Mark Ashley Robert, 37, "put the device on the railroad track in the early

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

as man pleaded guilty Thursday to one count of misinformation and hoaxes related to a Dec. 2018 case where he planted a fake bomb in the middle of a Kansas City Rail Line railroad track in Dallas, according to the U.S. Department of Justice." Mark Ashley Robert, 37, "put the device on the railroad track in the early

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

s man pleaded guilty Thursday to one count of misinformation and hoaxes related to a Dec. 2018 case where he planted a fake bomb in the middle of a Kansas City Rail Line railroad track in Dallas, according to the U.S. Department of Justice." Mark Ashley Robert, 37, "put the device on the railroad track in the early

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug